CHU de RENNES-Service des Maladies de l'Appareil Digestif
Rennes, France
Location status: Recruiting
Location contact
Guillaume BOUGUEN, Professor
CONTACT
NCT Number: NCT05294107
Over the last decade, the use of mini-organ or organoids has been increasingly developed in fundamental research. Indeed, digestive organoids represent an essential advance compared to classical culture systems (epithelial cell lines, immortalized cells) since they preserve in culture the functional complexity present in vivo (architecture, different cell types). They also have the advantage of being able to be propagated indefinitely (unlike explants), minimizing the use of animal models and reducing the amount of tissue required. Finally, their growth and development depends on the origin of the sample (the organoid will develop differently if the cell source comes from a patient suffering from an inflammatory bowel disease, for example), thus generating models of human pathologies to better determine their physiopathology. The use of organoids in biomedical research has proven to be an indispensable tool for the understanding of cellular and molecular mechanisms involved in epithelial renewal and the screening of molecules and ingredients for applications in the health and agri-food sectors.
Interested in participating?
Request Info18 year–75 year
All sexes
Interventional
Not applicable
Rennes, France
Location status: Recruiting
Guillaume BOUGUEN, Professor
CONTACT
The project aims to generate a biocollection of 3D intestinal models from digestive biopsies with associated health data and to characterize them before using them for the screening of potential therapeutic molecules.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
After Verification of eligibility criteria, patient information and consent, digestive biopsies performed for the study are in addition to those performed for the patient's follow-up:
Biopsies will be then prepared by isolating intestinal crypts and cultured on a 3D matrix gel (matrigel) with added growth factors reproducing the niche environment of intestinal stem cells, which favors the development of an intestinal epithelium. After intestinal differentiation, organoids will be used for research such as molecular screening, assessment of the effects of intestinal stress and healing.
Time frame: Day 0
Biopsies will be then prepared by isolating intestinal crypts and cultured on a 3D matrix gel (matrigel) with added growth factors reproducing the niche environment of intestinal stem cells, which favors the development of an intestinal epithelium. After intestinal differentiation, organoids will be used for research such as molecular screening, assessment of the effects of intestinal stress and healing.
Time frame: Day 0
Time frame: Day 0
Time frame: Day 0
Time frame: Day 0
Contact information is provided by the study sponsor or research team.
Rennes University Hospital
Other
Acronym: BIOÏDES
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02647866
Abdominal Pain, Autoimmune Disease
Greenville, South Carolina, United States
View Trial DetailsNCT02503696
Colonic Diseases, Colorectal Cancer
Dothan, Alabama, United States
View Trial DetailsNCT07222800
Colonic Diseases, Colonic Neoplasms
Chandler, Arizona, United States
View Trial DetailsNCT07351071
Anastomotic Complication, Anastomotic Leak
New Haven, Connecticut, United States
View Trial Details